Condition
Refractory Heart Failure
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Recruiting1
Not Yet Recruiting1
Completed1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07252531Not ApplicableNot Yet RecruitingPrimary
European Study of the BrioVAD Heart Pump for Advanced Heart Failure
NCT05876000Not ApplicableRecruitingPrimary
Corheart 6 LVAS Study
NCT01758627Not ApplicableCompletedPrimary
The Role of Peritoneal Dialysis in Patients With Refractory Heart Failure and Chronic Kidney Disease
NCT01001793Not ApplicableTerminatedPrimary
Levacor™ Ventricular Assist Device (VAD) Bridge to Transplant Study
Showing all 4 trials